Form 4: Vertex Pharmaceuticals EVP and CMO, Carmen Bozic, Reports Stock Sale

Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, sold 2,280 shares of common stock at a price of $487.34 per share on July 10, 2024, according to a Form 4 filing.

Summary

• Carmen Bozic, the Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals, reported a transaction involving the company's common stock.
• On July 10, 2024, Bozic sold 2,280 shares of Vertex Pharmaceuticals common stock.
• The sale price was $487.34 per share.
• Following the transaction, Bozic directly owns 27,819 shares of Vertex Pharmaceuticals common stock.
• The transaction was executed under a pre-arranged trading plan (Rule 10b5-1) established on February 27, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

Insider sales are a common occurrence and are often related to personal financial planning rather than a reflection of the executive's view of the company's prospects.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating a slight downward pressure on the stock price in the short term.

Key Dates